Da Li
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
-
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Hongming Pan (6 shared papers)Mengting Tong (5 shared papers)Yanling Wang (4 shared papers)Bowen Li (2 shared papers)Xiaojie Xu (2 shared papers)Honglin Tang (2 shared papers)Yuxuan Chen (1 shared paper)Huhu Xin (1 shared paper)
- Journals
- PLoS ONE (3 papers)BioMed Research International (2 papers)Scientific Reports (2 papers)Frontiers in Pharmacology (1 paper)Cell Proliferation (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Da Li
29 papers receiving 749 citations
Peers
Comparison fields: 5 of 88
- Oncology 254
- Cancer Research 108
- Immunology 123
- Molecular Biology 246
- Biomedical Engineering 161
Countries citing papers authored by Da Li
This map shows the geographic impact of Da Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Li more than expected).
Fields of papers citing papers by Da Li
This network shows the impact of papers produced by Da Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Li. The network helps show where Da Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Da Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 187 | |
| 2 | 2018 | 132 | |
| 3 | 2011 | 99 | |
| 4 | 2018 | 78 | |
| 5 | 2015 | 62 | |
| 6 | 2019 | 34 | |
| 7 | 2022 | 33 | |
| 8 | 2019 | 29 | |
| 9 | 2019 | 21 | |
| 10 | 2018 | 17 | |
| 11 | 2014 | 12 | |
| 12 | 2018 | 12 | |
| 13 | 2023 | 8 | |
| 14 | 2020 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 4 | |
| 18 | The cardio-protection of Salvia miltiorrhiza Ligustrazine Hydrochloride and Glucose Injection on myocardial ischemia-reperfusion injury in mice | 2012 | 3 |
| 19 | 2016 | 3 | |
| 20 | 2024 | 2 |
About Da Li
Da Li is a scholar working on Oncology, Surgery, Biomedical Engineering, Molecular Biology and Pathology and Forensic Medicine, having authored 35 papers that have together received 762 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer Genomics and Diagnostics (2 papers), Gastrointestinal motility and disorders (2 papers), Cannabis and Cannabinoid Research (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Oncology (254 citations), Cancer Research (108 citations), Immunology (123 citations), Molecular Biology (246 citations) and Biomedical Engineering (161 citations). Da Li has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Hongming Pan, Mengting Tong, Yanling Wang, Bowen Li, Xiaojie Xu, Honglin Tang, Yuxuan Chen, Huhu Xin, Tao Wan and Weidong Han. Their work appears in journals such as PLoS ONE, BioMed Research International, Scientific Reports, Frontiers in Pharmacology and Cell Proliferation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.